Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

InVivoMAb Anti-Poliovirus Capsid protein VP1 (19B)

Catalog #:   VVV25902 Specific References (27) DATASHEET
Host species: Human
Isotype: VHH-hFc
Applications: ELISA, Neutralization
Accession: P03300
Overview

Catalog No.

VVV25902

Species reactivity

Poliovirus type 1 (strain Mahoney)

Host species

Human

Isotype

VHH-hFc

Clonality

Monoclonal

Target

Genome polyprotein, Capsid protein VP1, Capsid protein VP2

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P03300

Applications

ELISA, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

19B

Data Image
References

Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo., PMID:29337652

Trypsin diminishes the rat potency of polio serotype 3., PMID:26321654

Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement., PMID:22078110

Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man., PMID:15135598

Replication of a hepatitis A virus replicon detected by genetic recombination in vivo., PMID:12185272

Immunogenicity of viral B-cell epitopes inserted into two surface loops of the Escherichia coli K12 LamB protein and expressed in an attenuated aroA strain of Salmonella typhimurium., PMID:10078601

Variability in the integrity of human enteroviruses exposed to various simulated in vivo environments., PMID:9790872

In vivo T helper cell response to retro-inverso peptidomimetics., PMID:9317121

Phage display of intact domains at high copy number: a system based on SOC, the small outer capsid protein of bacteriophage T4., PMID:8880907

A study of the cellular immune response to enteroviruses in humans: identification of cross-reactive T cell epitopes on the structural proteins of enteroviruses., PMID:8811009

Overcoming the crypticity of a viral T cell determinant by insertion into a chimeric bacterial protein., PMID:8918694

Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts., PMID:7483265

Molecular context of a viral T cell determinant within a chimeric bacterial protein alters the diversity of its T cell recognition., PMID:7515911

Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell., PMID:8389907

Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase., PMID:1656088

Specificity of the polioviral proteinase 3C towards genetically engineered cleavage sites in the viral capsid., PMID:1851816

Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles., PMID:2166807

Immunogenicity of foreign peptide epitopes expressed in bacterial envelope proteins., PMID:1714094

A mutant poliovirus containing a novel proteolytic cleavage site in VP3 is altered in viral maturation., PMID:2157059

Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1., PMID:1689392

Antigenic modification of polioviruses by host proteolytic enzymes., PMID:2158286

Poliovirus proteinase 3C: large-scale expression, purification, and specific cleavage activity on natural and synthetic substrates in vitro., PMID:2846872

Capsid protein VP4 of poliovirus is N-myristoylated., PMID:2825164

Binding site of neutralizing monoclonal antibodies obtained after in vivo priming with purified VP1 of poliovirus type 1 is located between amino acid residues 93 and 104 of VP1., PMID:2435056

In vivo proteins of defective interfering particles of poliovirus., PMID:6331618

Induction of neutralizing antibodies by poliovirus capsid polypeptides VP1, VP2 and VP3., PMID:6099638

The physicochemical properties of infectious hepatitis A virions., PMID:6172556

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

InVivoMAb Anti-Poliovirus Capsid protein VP1 (19B) [VVV25902]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only